Physician profile
Michael Kleeman
NPI 1063445138
$7,128.26
in general payments reported to CMS, 2019-2025
45 companies · $1,241 in 2025
The $1,241 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,284 · 2020: $208 · 2021: $776 · 2022: $1,119 · 2023: $1,373 · 2024: $1,128 · 2025: $1,241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,562 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,562.28 |
| Education | $179.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,123.81 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $1,026.32 | 2019-2025 | Myrbetriq, Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $710.39 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $537.46 | 2023-2025 | Orgovyx, Gemtesa |
| Teleflex LLC | $509.37 | 2021-2025 | Urolift, Barrigel |
| Dendreon Pharmaceuticals LLC | $489.66 | 2019-2025 | Provenge |
| 180 Medical, INC. | $246.36 | 2019-2025 | |
| Myovant Sciences INC. | $233.46 | 2021-2022 | |
| Pfizer INC. | $197.44 | 2019-2021 | |
| Accord Healthcare, INC. | $169.18 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $158.85 | 2022-2023 | Seglentis, Livalo |
| Coloplast Corp | $152.58 | 2019-2025 | Speedicath |
| Endo Pharmaceuticals INC. | $136.55 | 2019-2021 | |
| Endo USA, INC. | $131.94 | 2024-2025 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $131.41 | 2024-2025 | Adstiladrin |
Show all 44 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$221,200.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kleeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.